Management of Clostridium Difficile Infection

Slides:



Advertisements
Similar presentations
Relapsing and Severe C. difficile Disease Role of Fecal Microbiota Transfer.
Advertisements

Jayesh Patel, MD, DTM&H Infectious Disease Consultant Chair Infection Prevention and Pharmacy/Therapeutics/Nutrition (Skyline)
Lower Gastrointestinal Bleeding
Colitis in the Very Young
Clostridium difficile Presented by Nate Smith, MD, MPH Carole Yeung, RN CIC.
Clostridium Difficile (C.diff): Fast Facts. What is Clostridium difficile (C. diff)? C. diff is a bacteria that lives in the intestinal tract of about.
NYU Medical Grand Rounds Clinical Vignette Rennie Rhee MD, PGY-2 January 13, 2010 U NITED S TATES D EPARTMENT OF V ETERANS A FFAIRS.
Tessa Bandhan. Question 1 A 3 year old girl known to have sickle cell disease (Hb SS) presents to the Emergency Room with a 2 day history of weakness.
C. Difficile and Fecal Microbiota Therapy
Clostridium difficile Colitis. C. diff.—Gram stain.
Management of Clostridium difficile Infections
Progress in Diagnosing and Treating Clostridium difficile in IBD patients Alan C. Moss MD, FEBG, FACG, AGAF Associate Professor of Medicine Director of.
Anemia Lab MHD I November 3, Case 1 A CBC is ordered on a 32-year old healthy man as part of a life-insurance policy evaluation.
Monday AM report
PROGRESS NOTE (SOAP Notes)
Core Topic UCI Internal Medicine Residency Learning Objectives Review the major causes of upper GI bleeding and important elements of the history.
شاهین زارع.
GASTROINTESTINAL BLEEDING
What is the Deal About FMT? Herbert L. DuPont, MD Director, Center for Infectious Diseases, University of Texas School of Public Health President, Kelsey.
Ulcerative colitis.
NYU Medical Grand Rounds Clinical Vignette Lindsay Innes, MD PGY2 September 20, 2011 U NITED S TATES D EPARTMENT OF V ETERANS A FFAIRS.
 Total or segmental nonobstructive colonic dilatation  PLUS systemic toxicity  Most commonly transverse colon.
NYU Medical Grand Rounds Clinical Vignette Andy Levy, MD PGY-2 March 26, 2013 U NITED S TATES D EPARTMENT OF V ETERANS A FFAIRS.
M&M Conference Michelle Hamel, PGY-5
Spontaneous Bacterial Peritonitis Katherine Yu May 2014.
Clinical Vignette: Medical Grand Rounds Joshua L. Denson MD Internal Medicine PGY2 January 7, 2013 U NITED S TATES D EPARTMENT OF V ETERANS A FFAIRS.
Upper Gastrointestinal Disease Bradley J. Phillips, MD Burn-Trauma-ICU Adults & Pediatrics.
It's Time A 63-year-old woman was admitted because of severe abdominal pain, fatigue and bloody diarrhea.
Red blood cell disorders / Anemia laboratory
A Clinician’s Approach to Treatment.  To understand the definition of cellulitis  To know what treatment is appropriate  To know when hospitalization.
Clostridium Difficile Infection:
R1 김동연 /prof. 이창균. Introduction  Recurrent Clostridium difficile infection is difficult to treat, and failure rates for antibiotic therapy are high.
R3 민준기 Pf. 이창균. Introduction 1978 – Clostridium difficile major cause of diarrhea – Pseudomembranous colitis associated with the use of antimicrobial.
Don’t Let Your Sinus Infection Turn Into a Life Threatening Colon Infection.
© 2013 Pearson Education, Inc. Bell Ringer  What is an endospore, and what special characteristics do endospore forming bacteria have?
JAMA Internal Medicine May 2015 Volume 175, Number5 R1 조한샘 / Prof. 이창균.
65 year old White male presents complaining of diffuse, crampy abdominal pain. He began vomiting a few hours ago and feels very nauseated. His last bowel.
Sepsis Tutoring By Alaina Darby.
A gastrointestinal problem
Documentation of pharmaceutical care
Liver Disease tutoring Part 2
Background Information
Clostridium difficile disease Management: Flagyl to Fecal Transplants – A Step Wise Approach to C. difficile colitis September 22, 2017 CSGNA Pamela Kibsey.
From: Effect of Fecal Microbiota Transplantation on Recurrence in Multiply Recurrent Clostridium difficile InfectionA Randomized Trial Ann Intern Med.
Palliative Care in the Outpatient Setting: Pain Management
C. difficile Detection and the Importance of Proper Specimen Collection and Testing [Name] [Title]
ULCERATIVE COLITIS Dr.Mohammadzadeh.
PBL Case Discussion ——acute abdomen 刘佳滟 朱晓一.
HTN Cases Pharmacotherapy - 1.
Acute Abdomen Mohammed Al-Naami FRCSC, FACS, M Ed.
Antimicrobial Therapy (Vancomycin and/or Metronidazole)
Clostridium difficile Infection (CDI) Guideline Update: Understanding the Data Behind the Recommendations Erik R. Dubberke, MD, MSPH Associate Professor.
APIC Chapter 13 Journal Club
C. difficile update: Implications for antibiotic stewardship
Update on Clostridium difficile Infection
Oral Vancomycin as a Therapeutic Option for PSC
European Society of Clinical Microbiology and Infectious Diseases: Update of the Treatment Guidance Document for Clostridium difficile Infection  S.B.
Six Microskills for Clinical Teaching
Treatment Update on Clostridium difficile Infection
Clostridium difficile Update
CLINICAL SOLVING PROBLEM
Meningitis.
CASE 5.
C. difficile Update Kim Vermedal, RN, MSN, CIC APIC January 25, 2019.
Train-the-Trainer Cases
Heavy Lies the Helmet Episode #30 Case Studies.
Train-the-Trainer Cases
Train-the-Trainer Cases
C. diff Testing Stewardship
Presentation transcript:

Management of Clostridium Difficile Infection UC Irvine Medical Center Department of Internal Medicine 05/2018 Mitch Edwards, D.O.

Objectives Define the severity of Clostridium Difficile Infection (CDI) Learn how to treat CDI by degree of severity Learn how to treat recurrent CDI

Approach to treatment How severe is the disease? Non-severe disease Severe disease Fulminant disease (previously known as severe complicated CDI) Is this the first episode, or is it recurrent infection? Initial First recurrence Second or subsequent recurrence

CDI Disease Severity: Nonsevere vs severe/fulminant Does that patient have any of the following: WBC ≥ 15,000 Creatinine ≥1.5 Guideline parameters for severe CDI include white blood cell count of >15,000 cells/microL, and/or a serum creatinine level ≥1.5 times the premorbid level Nonsevere disease No Yes Severe or Fulminant Disease

Severe vs Fulminant No Yes Does the patient have any of the following? Hypotension/shock Ileus Toxic Megacolon Severe disease No Yes Fulminant Disease

Management of First Time CDI Nonsevere disease: Vancomycin 125 mg orally four times a day for a total of 10 days, OR Fidaxomicin 200mg twice a day for 10 days If above agents are unavailable: Metronidazole 500mg three times a day for 10 days Severe disease: Vancomycin 125 mg orally four times a day for 10 days, OR Fidaxomicin 200 mg orally twice a day for 10 days Notice how metronidazole is NOT first line for non-severe disease

Management of Fulminant CDI Vancomycin 500mg PO or via NG tube QID, PLUS Metronidazole 500mg IV TID If ileus is present (or if oral antibiotics are not expected to reach a segment of the colon): Rectal vancomycin may be administered as a retention enema (500mg in 100 mL normal saline per rectum; retained as long as possible, and readministered every 6 hours) Examples of when oral antibiotics may not reach a segment of the colon: ileus, megacolon, Hartman’s pouch, ileostomy, colon diversion

Recurrent CDI First recurrence: If vancomycin was used for the initial episode: Vancomycin oral pulsed-taper for 6 weeks, OR Fidaxomicin 200mg BID for 10 days If fidaxomicin or flagyl was used for the initial episode: Vancomycin 125mg PO QID for 10 days Second recurrence or subsequent recurrence: Tapering and pulsed oral vancomycin, OR Fidaxomicin 200mg BID for 10 days, OR Vancomycin followed by Rifaximin Vancomycin 125mg PO QID for 10 days, then Rifaximin 400mg TID for 20 days, OR Fecal microbiota transplantation Vancomycin pulsed taper is as follows: 125 mg orally QID daily for 10 to 14 days, then BID for 7 days, then QD for 7 days, then q48h-q72h for 2-8 weeks Despite appropriate initial therapy, CDI recurs in approximately 20% of patients The choice of therapy for the 1st recurrence does not decrease the probability of a 2nd recurrence

Case- Part A A 42 year-old man is evaluated for diarrhea in the emergency department. He has been having 6-8 episodes of watery diarrhea associated with crampy abdominal pain and occasional fevers at home for the past week. He feels fatigued. He has never had anything like this before. Vitals are noted to be: BP 125/82, HR 94, RR 20, T-100.4 F, SaO2 98% on room air. Physical exam shows a soft and mildly tender to palpation abdomen diffusely without peritoneal signs. Labs are significant for a WBC of 12.1K, Hgb 14.6, Na 129, K 3.8, BUN 24, and Cr 1.0. His stool C. diff PCR is positive. What is the most appropriate treatment for this patients CDI? Metronidazole 500mg TID for 14 days Vancomycin 125mg QID for 10 days Vancomycin pulse-tapered regimen for 6 weeks Vancomycin 500mg PO QID plus IV metronidazole 500mg TID

Case- Part A A 42 year-old man is evaluated for diarrhea in the emergency department. He has been having 6-8 episodes of watery diarrhea associated with crampy abdominal pain and occasional fevers at home for the past week. He feels fatigued. He has never had anything like this before. Vitals are noted to be: BP 125/82, HR 94, RR 20, T-100.4 F, SaO2 98% on room air. Physical exam shows a soft and mildly tender to palpation abdomen diffusely without peritoneal signs. Labs are significant for a WBC of 12.1K, Hgb 14.6, Na 129, K 3.8, BUN 24, and Cr 1.0. His stool C. diff PCR is positive. What is the most appropriate treatment for this patients CDI? Metronidazole 500mg TID for 14 days Vancomycin 125mg QID for 10 days Vancomycin pulse-tapered regimen for 6 weeks Vancomycin 500mg PO QID plus IV metronidazole 500mg TID The patient has a first time CDI, that is non-severe (WBC <15,000 and Cr <1.5 without evidence of shock or ileus). Treatment of this is now either with vancomycin 125mg QID for 10 days or fidaxomicin 200mg BID for 10 days. If one of those agents is not available, then you can use metronidazole 500mg TID for 10 days. Vancomycin in a pulse-tapaered fashion is only used for recurrent C. diff, and vancomycin plus IV flagyl is used for fulminant C. diff.

Case- Part B The same patient visits you in your office 4 weeks after completing his 10 day course of vancomycin. He is now complaining of similar symptoms, with 3 watery bowel movements a day, abdominal pain, and fevers at home for the past 2 days. His vitals in the office are: BP 126/80, HR 72, RR 18, T- 98.6. He overall feels ok, and agrees to getting labs today in the office and going home. A CBC is significant for a WBC of 13k, and his serum Cr is 1.1. Stool C. diff PCR is again positive. You call him to let him know he has C. diff again, and that you are sending a prescription to his pharmacy to treat it. What antibiotic(s) are you sending to his pharmacy? Vancomycin 125mg QID for 10 days Metronidazole 500mg QID for 10 days Vancomycin pulse-taper for 6 weeks Vancomycin 125mg QID for 10 days then Rifaximin 400mg TID for 20 days Fecal transplant

Case- Part B The same patient visits you in your office 4 weeks after completing his 10 day course of vancomycin. He is now complaining of similar symptoms, with 3 watery bowel movements a day, abdominal pain, and fevers at home for the past 2 days. His vitals in the office are: BP 126/80, HR 72, RR 18, T- 98.6. He overall feels ok, and agrees to getting labs today in the office and going home. A CBC is significant for a WBC of 13k, and his serum Cr is 1.1. Stool C. diff PCR is again positive. You call him to let him know he has C. diff again, and that you are sending a prescription to his pharmacy to treat it. What antibiotic(s) are you sending to his pharmacy? Vancomycin 125mg QID for 10 days Metronidazole 500mg QID for 10 days Vancomycin pulse-taper for 6 weeks Vancomycin 125mg QID for 10 days then Rifaximin 400mg TID for 20 days Fecal transplant The patient has a 1st time recurrence of a CDI. It again is a non-severe infection. Because vancomycin was used the for the first infection, you could either use a vancomycin pulse-tapered regimen for 6 weeks, or you could use fidaxomicin 200mg BID for 10 days. Metronidazole PO is not used for a first time recurrence. Vancomycin PO for 10 days then PO rifaxmin for 20 days can be used for a second or subsequent recurrence, but this is his first recurrence. Fecal transplant is also only used in a second or subsequent recurrence.

Key Points Treatment is based on severity of infection (nonsevere, severe, fulminant) and recurrence For non-severe or severe, initial treatment is vancomycin or fidaxomicin for 10 days Treatment of fulminant CDI is with oral vancomycin plus IV flagyl, and can add rectal vancomycin if ileus is present Treat 1st recurrence with pulse tapered vancomycin or fidaxomicin Treat second or subsequent recurrences with either pulse-tapered vancomycin, fidaxomicin, vancomycin followed by rifaximin, and/or fecal microbiota transplantation

The End

References Up-to-date Article: Clostridium difficile in adults: Treatment: https://www.uptodate.com/contents/clostridium-difficile-infection-in-adults-treatment-and-prevention?search=C.%20diff&source=search_result&selectedTitle=1~150&usage_type=default&display_rank=1#H1525206458